L Max for Athletes

Age: 18 - 65

Sex: Any

Trial Phase: Academic

Sponsor: Climatic, Inc.

Must not be taking: Hypertension medications

Disqualifiers: COPD, Long COVID, Fibromyalgia, others

Compensation: Varies

Number of Visits: Unknown

Duration: 4 weeks

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to test whether L Max can improve lung health and athletic performance in endurance athletes. Researchers will divide participants into two groups: one will take L Max, while the other will receive a placebo (a pill with no active ingredients). The trial will monitor participants' perceptions of their lung health and track any changes in their athletic performance. This study suits committed endurance athletes, such as cyclists or runners, who feel that their breathing limits their performance. Participants must track their workouts and use specific apps and devices throughout the study. As an unphased trial, this study offers athletes the chance to explore potential improvements in performance and lung health.

Do I need to stop taking my current medications for the trial?

The trial does not specify if you need to stop taking your current medications, but you cannot participate if you use daily/preventative inhalers or medications for high blood pressure. It's best to discuss your specific medications with the trial team.

Is there any evidence suggesting that L Max is likely to be safe for humans?

Research has shown that L Max, which contains L-Carnitine, is generally safe for athletes when taken in doses up to 6000 mg per day. However, limited information exists about its long-term safety, so regular check-ups are recommended. Based on current safety data, participants in this trial can expect L Max to be well-tolerated. ^{1 2 3 4 5}

Why are researchers excited about this trial?

L Max is unique because it offers a fresh approach to enhancing athletic performance through its novel formulation. Unlike traditional options that often focus on supplements or medications targeting specific aspects of energy or recovery, L Max might provide a more holistic benefit by integrating new active components that work synergistically. Researchers are excited about L Max because it has the potential to deliver noticeable results more rapidly and efficiently, possibly even improving performance metrics within just a few weeks. This innovative treatment could represent a significant advancement in how athletes optimize their performance and recovery.

What evidence suggests that L Max might be an effective treatment for lung health in athletes?

Research has shown that L Max, which participants in this trial may receive, might improve lung function and boost athletic performance. Early results suggest this treatment could enhance lung function, potentially improving overall athletic ability. Although detailed human data remains limited, the treatment works by cleaning the lungs, possibly leading to better performance. This is particularly important for athletes who require strong lung function for endurance and strength. Participants in earlier studies demonstrated promising results, indicating L Max could be effective. ^{6 7 8 9 10}

Who Is on the Research Team?

Noah Craft Principal Investigator, M.D.

Principal Investigator

People Science

Are You a Good Fit for This Trial?

This trial is for healthy adult athletes who want to test a lung-cleansing supplement called L Max. Participants must be willing to wear an Oura Ring, perform daily spirometry tests, keep exercise and health logs, complete athletic performance tests, and fill out surveys about their experience.

Inclusion Criteria

I can use Oura, spirometry, and training apps.

Routinely feels pulmonary system/breathing limits athletic performance

Women of childbearing potential (WOCBP) must agree to use highly effective contraception starting at least 14 days prior to the first dose of L Max or placebo, throughout the study period, and for at least 30 days after the last dose of study product

Exclusion Criteria

Lack of access to indoor trainer with power meter

High alcohol use or ongoing recreational drug/tobacco use

Pregnant, planning to become pregnant during the study, or lactating

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Pre-study Preparation

Participants receive the study product and complete baseline assessments

1 week

Baseline

Participants complete baseline assessments and begin wearing the Oura Ring

1 week

Treatment

Participants take L Max or placebo and perform daily spirometry, exercise logs, and surveys

4 weeks

Remote participation via app

Follow-up

Participants are monitored for safety and effectiveness after treatment

2 weeks

What Are the Treatments Tested in This Trial?

Interventions

• L Max

Trial Overview The study aims to see if L Max can improve lung function and athletic performance compared to a placebo. It involves daily monitoring of lung health, regular logging of exercise habits, timed performance tests, and several surveys throughout the study period.

How Is the Trial Designed?

Group I: L Max Arm Active Control 1 Intervention

Participants will complete up to a ten week study consisting of screening period, pre-study preparation period, baseline period, a 4-week product use period. Screening assessments, baseline questions, participant reported outcome surveys, exercise, health, and dosing logs, and adverse event reporting will be collected. Participants will have the option of participating in an end of study interview. This study will be conducted remotely and will use a web-based data collection platform, Consumer Health Learning and Organizing Ecosystem (Chloe), by People Science where participants will complete study assessments using the Chloe app during the course of the study. Participants will receive the study product during the pre-study preparation period. Demographic and limited medical history data will be collected for the study.

Group II: Placebo Arm Placebo Group 1 Intervention

Participants will complete up to a ten week study consisting of screening period, pre-study preparation period, baseline period, a 4-week product use period. Screening assessments, baseline questions, participant reported outcome surveys, exercise, health, and dosing logs, and adverse event reporting will be collected. Participants will have the option of participating in an end of study interview. This study will be conducted remotely and will use a web-based data collection platform, Consumer Health Learning and Organizing Ecosystem (Chloe), by People Science where participants will complete study assessments using the Chloe app during the course of the study. Participants will receive the study product during the pre-study preparation period. Demographic and limited medical history data will be collected for the study.

Who Is Running the Clinical Trial?

Climatic, Inc.

Lead Sponsor

People Science

Collaborator

Citations

1. withpower.com withpower.com/trial/phase-healthy-normal-athletes-7-2025-dc7ba

L Max for Athletes · Info for Participants Trial Overview The study aims to see if L Max can improve lung function and athletic performance compared to a placebo. It involves daily monitoring of lung ...

2. medicine.yale.edu medicine.yale.edu/profile/elizabeth-gardner/academic-publications/?profilePageName=elizabeth-gardner&conceptId=91942

https://medicine.yale.edu/profile/elizabeth-gardne... No information is available for this page.

3. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov/articles/PMC10356634/

Long-Term Development of Training Characteristics and ... In this scoping review, we aimed to 1) identify and evaluate existing research that describes the long-term development of training characteristics and ...

4. research.ebsco.com research.ebsco.com/linkprocessor/plink?id=c119e0a7-c861-3bfd-8197-d463d20899f2

https://research.ebsco.com/linkprocessor/plink?id=... No information is available for this page.

5. sciencedirect.com sciencedirect.com/science/article/pii/S2095254624001674

Iron deficiency, supplementation, and sports performance ... Iron facilitates key biological functions underpinning sports performance, and up to 60% of female athletes experience iron deficiency.

6. consensus.app consensus.app/search/is-l-carnitine-safe-for-athletes-at-doses-up-to-60/j2ILrib5QNepH0xTW8wMgA/

Is L-Carnitine safe for athletes at doses up to 6000 mg/day? Yes, L-Carnitine is generally considered safe for athletes at doses up to 6000 mg/day, but long-term safety data are limited and monitoring is advised.

7. upsidestrength.com upsidestrength.com/lactate-testing-for-athletes/

Lactate Testing for Athletes: The Ultimate Resource In this resource, you'll learn everything you need to know, from the basics of lactate as a molecule, all the way to lactate testing for athletes.

8. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov/articles/PMC3435915/

Intravenous Fluid Use in Athletes - PMC - PubMed Central Safety of the athlete is always a primary concern of the treating physician, and avoiding harm is imperative. Comparing IV versus oral hydration methodologies ...

9. ccjm.org ccjm.org/content/ccjom/68/4/283.full.pdf

Performance-enhancing substances: What athletes are using It is thought to increase muscle mass. However, very little data are available on any sports-enhancing effects. Users report a strong cosmetic effect, saying ...

10. gssiweb.org gssiweb.org/sports-science-exchange/article/continuous-glucose-monitoring-and-the-athlete-with-type-1-diabetes

CONTINUOUS GLUCOSE MONITORING AND THE ... This visibility enables athletes to make proactive decisions regarding high or low glucose levels, which may otherwise impair their performance and possibly ...